Skip to content
10-Q

Quarterly Report

Jade Biosciences, Inc. JBIO

0001193125-25-281525

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 46M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 23.82M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3.16M sh
Capex Q3 2025 · Sep 30, 2025 $193K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$61.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.8M
Short Term Investments Q3 2025 · Sep 30, 2025 $148.8M
Short Term Investments Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $50.11M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $69.39M
Stockholders Equity Q3 2025 · Sep 30, 2025 $179.35M
Stockholders Equity Q3 2025 · Jun 30, 2025 $201.56M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$83.51M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$46.8M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$16.86M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$589K
Stockholders Equity Q3 2025 · Jun 17, 2024 $1K
Current Liabilities Q3 2025 · Sep 30, 2025 $22.36M
Current Liabilities Q3 2025 · Dec 31, 2024 $12M
Total Liabilities Q3 2025 · Sep 30, 2025 $23.1M
Total Liabilities Q3 2025 · Dec 31, 2024 $119.6M
Current Assets Q3 2025 · Sep 30, 2025 $201.36M
Current Assets Q3 2025 · Dec 31, 2024 $69.65M
Total Assets Q3 2025 · Sep 30, 2025 $202.45M
Total Assets Q3 2025 · Dec 31, 2024 $72.8M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.08
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$5.16
Eps Diluted Q3 2025 · Sep 30, 2024 −$5.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 −$3.08
Eps Basic restated Q3 2025 · Sep 30, 2024 −$5.16
Eps Basic Q3 2025 · Sep 30, 2024 −$5.35
Sga Expense Q3 2025 · Sep 30, 2025 $5.39M
Sga Expense Q3 2025 · Sep 30, 2025 $13.98M
Sga Expense restated Q3 2025 · Sep 30, 2024 $1.38M
Sga Expense Q3 2025 · Sep 30, 2024 $1.9M
Rd Expense Q3 2025 · Sep 30, 2025 $22.01M
Rd Expense Q3 2025 · Sep 30, 2025 $64.58M
Rd Expense restated Q3 2025 · Sep 30, 2024 $13.58M
Rd Expense Q3 2025 · Sep 30, 2024 $13.66M
Net Income Q3 2025 · Sep 30, 2025 −$25.18M
Net Income Q3 2025 · Sep 30, 2025 −$95.48M
Net Income Q3 2025 · Jun 30, 2025 −$32.13M
Net Income Q3 2025 · Mar 31, 2025 −$38.17M
Net Income restated Q3 2025 · Sep 30, 2024 −$16.28M
Net Income Q3 2025 · Sep 30, 2024 −$16.87M
Net Income Q3 2025 · Jun 30, 2024 −$590K
Operating Income Q3 2025 · Sep 30, 2025 −$27.4M
Operating Income Q3 2025 · Sep 30, 2025 −$78.56M
Operating Income restated Q3 2025 · Sep 30, 2024 −$14.97M
Operating Income Q3 2025 · Sep 30, 2024 −$15.56M